Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery

We investigated the ability of a plasmid-derived IL-21 delivered alone or in combination with the IL-15 gene to regulate immune responses to the HIV-1 envelope (Env) glycoprotein induced by DNA vaccination. Mice were injected with the gp140DeltaCFI(HXB2/89.6) vector expressing a modified Env glycopr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Immunology 2006-07, Vol.177 (1), p.177-191
Hauptverfasser: Bolesta, Elizabeth, Kowalczyk, Aleksandra, Wierzbicki, Andrzej, Eppolito, Cheryl, Kaneko, Yutaro, Takiguchi, Masafumi, Stamatatos, Leonidas, Shrikant, Protul A, Kozbor, Danuta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 191
container_issue 1
container_start_page 177
container_title Journal of Immunology
container_volume 177
creator Bolesta, Elizabeth
Kowalczyk, Aleksandra
Wierzbicki, Andrzej
Eppolito, Cheryl
Kaneko, Yutaro
Takiguchi, Masafumi
Stamatatos, Leonidas
Shrikant, Protul A
Kozbor, Danuta
description We investigated the ability of a plasmid-derived IL-21 delivered alone or in combination with the IL-15 gene to regulate immune responses to the HIV-1 envelope (Env) glycoprotein induced by DNA vaccination. Mice were injected with the gp140DeltaCFI(HXB2/89.6) vector expressing a modified Env glycoprotein with C-terminal mutations intended to mimic a fusion intermediate, in which the most divergent region encoding the variable V1, V2, and V3 domains of CXCR4-tropic HxB2 virus was replaced with the dual-tropic 89.6 viral strain. Using a recombinant vaccinia virus expressing 89.6 Env glycoprotein (vBD3) in a mouse challenge model, we observed that IL-21 plasmid produced sustained resistance to viral transmission when injected 5 days after DNA vaccination. Moreover, IL-21 in a synergistic manner with IL-15 expression vector augmented the vaccine-induced recall responses to the vBD3 challenge compared with those elicited by immunization in the presence of either cytokine alone. The synergistic combination of IL-21 and IL-15 plasmids promoted expansion of CD8+CD127+ memory T cell pools specific for a subdominant HLA-A2-restricted Env(121-129) epitope (KLTPLCVTL). Our results also show that coimmunization with IL-21 and IL-15 plasmid combination resulted in enhanced CD8+ T cell function that was partially independent of CD4+ T cell help in mediating protection against vBD3 challenge. Furthermore, the use of IL-21 and IL-15 genes was able to increase Ab-dependent cellular cytotoxicity and complement-dependent lysis of Env-expressing target cells through augmentation of Env-specific IgG Ab levels. These data indicate that the plasmid-delivered IL-21 and IL-15 can increase the magnitude of the response to DNA vaccines.
doi_str_mv 10.4049/jimmunol.177.1.177
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68098768</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68098768</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-9e4e003f29582841fb5dc873d182eef4ad4fb30e4828d8d724433a006036e8e53</originalsourceid><addsrcrecordid>eNqFUc1u00AQXiEQDYUX4ID2xM1h_3dzrNI0tRQVhKBXy16Pk63sdfDaMX4lnpI1Dcqxl5mR5vsZzYfQR0qWgojVlyfXNINv6yXVeknn-gotqJQkUYqo12hBCGMJ1UpfoXchPBFCFGHiLbqiShspKV-gP6m3HeQBSryDE9Q493Fq_R5Orp9wW-FvXduD7d0JcDr7Af4O4dj6AAGnvhxspBYTvn24wY-5tS4CNr-PHYTg_B73B8D36WNC8caf8LaebHucBZ3H4wE8XrdNESklHl1_wOkuYfTfCXGiEm8hqt1CHc276T16U-V1gA_nfo1-3m1-rO-T3ddtur7ZJZYr3icrEEAIr9hKGmYErQpZWqN5SQ0DqEReiqrgBETclqbUTAjO8_k1XIEBya_R52fdeOivAUKfNS5YqOvcQzuETBmyMlqZF4FUM0m1nIHsGWi7NoQOquzYuSbvpoySbI4y-x9l5OiMzjWSPp3Vh6KB8kI5Z3exP7j9YXQdZKHJ6zrCaTaO40XpL9_gqUY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17251758</pqid></control><display><type>article</type><title>Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery</title><source>MEDLINE</source><source>Wiley-Blackwell Free Backfiles(OpenAccess)</source><source>Wiley Online Library Journals</source><source>IngentaConnect Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Bolesta, Elizabeth ; Kowalczyk, Aleksandra ; Wierzbicki, Andrzej ; Eppolito, Cheryl ; Kaneko, Yutaro ; Takiguchi, Masafumi ; Stamatatos, Leonidas ; Shrikant, Protul A ; Kozbor, Danuta</creator><creatorcontrib>Bolesta, Elizabeth ; Kowalczyk, Aleksandra ; Wierzbicki, Andrzej ; Eppolito, Cheryl ; Kaneko, Yutaro ; Takiguchi, Masafumi ; Stamatatos, Leonidas ; Shrikant, Protul A ; Kozbor, Danuta</creatorcontrib><description>We investigated the ability of a plasmid-derived IL-21 delivered alone or in combination with the IL-15 gene to regulate immune responses to the HIV-1 envelope (Env) glycoprotein induced by DNA vaccination. Mice were injected with the gp140DeltaCFI(HXB2/89.6) vector expressing a modified Env glycoprotein with C-terminal mutations intended to mimic a fusion intermediate, in which the most divergent region encoding the variable V1, V2, and V3 domains of CXCR4-tropic HxB2 virus was replaced with the dual-tropic 89.6 viral strain. Using a recombinant vaccinia virus expressing 89.6 Env glycoprotein (vBD3) in a mouse challenge model, we observed that IL-21 plasmid produced sustained resistance to viral transmission when injected 5 days after DNA vaccination. Moreover, IL-21 in a synergistic manner with IL-15 expression vector augmented the vaccine-induced recall responses to the vBD3 challenge compared with those elicited by immunization in the presence of either cytokine alone. The synergistic combination of IL-21 and IL-15 plasmids promoted expansion of CD8+CD127+ memory T cell pools specific for a subdominant HLA-A2-restricted Env(121-129) epitope (KLTPLCVTL). Our results also show that coimmunization with IL-21 and IL-15 plasmid combination resulted in enhanced CD8+ T cell function that was partially independent of CD4+ T cell help in mediating protection against vBD3 challenge. Furthermore, the use of IL-21 and IL-15 genes was able to increase Ab-dependent cellular cytotoxicity and complement-dependent lysis of Env-expressing target cells through augmentation of Env-specific IgG Ab levels. These data indicate that the plasmid-delivered IL-21 and IL-15 can increase the magnitude of the response to DNA vaccines.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.4049/jimmunol.177.1.177</identifier><identifier>PMID: 16785513</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject><![CDATA[Adjuvants, Immunologic - administration & dosage ; Adjuvants, Immunologic - genetics ; AIDS Vaccines - administration & dosage ; AIDS Vaccines - genetics ; AIDS Vaccines - immunology ; Animals ; Antibody-Dependent Cell Cytotoxicity - genetics ; CD8-Positive T-Lymphocytes - immunology ; Combined Modality Therapy ; env Gene Products, Human Immunodeficiency Virus ; Female ; Gene Products, env - administration & dosage ; Gene Products, env - biosynthesis ; Gene Products, env - genetics ; Gene Transfer Techniques ; HIV Antibodies - biosynthesis ; HIV Antibodies - physiology ; HIV-1 - genetics ; HIV-1 - immunology ; Human immunodeficiency virus 1 ; Immunization, Secondary ; Interleukin-15 - administration & dosage ; Interleukin-15 - genetics ; Interleukins - administration & dosage ; Interleukins - genetics ; Interleukins - physiology ; Mice ; Mice, Inbred BALB C ; Mice, Transgenic ; Neutralization Tests ; Rabbits ; Vaccines, DNA - administration & dosage ; Vaccines, DNA - genetics ; Vaccines, DNA - immunology ; Vaccinia virus ; Vaccinia virus - genetics ; Vaccinia virus - immunology]]></subject><ispartof>Journal of Immunology, 2006-07, Vol.177 (1), p.177-191</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-9e4e003f29582841fb5dc873d182eef4ad4fb30e4828d8d724433a006036e8e53</citedby><cites>FETCH-LOGICAL-c363t-9e4e003f29582841fb5dc873d182eef4ad4fb30e4828d8d724433a006036e8e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16785513$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bolesta, Elizabeth</creatorcontrib><creatorcontrib>Kowalczyk, Aleksandra</creatorcontrib><creatorcontrib>Wierzbicki, Andrzej</creatorcontrib><creatorcontrib>Eppolito, Cheryl</creatorcontrib><creatorcontrib>Kaneko, Yutaro</creatorcontrib><creatorcontrib>Takiguchi, Masafumi</creatorcontrib><creatorcontrib>Stamatatos, Leonidas</creatorcontrib><creatorcontrib>Shrikant, Protul A</creatorcontrib><creatorcontrib>Kozbor, Danuta</creatorcontrib><title>Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery</title><title>Journal of Immunology</title><addtitle>J Immunol</addtitle><description>We investigated the ability of a plasmid-derived IL-21 delivered alone or in combination with the IL-15 gene to regulate immune responses to the HIV-1 envelope (Env) glycoprotein induced by DNA vaccination. Mice were injected with the gp140DeltaCFI(HXB2/89.6) vector expressing a modified Env glycoprotein with C-terminal mutations intended to mimic a fusion intermediate, in which the most divergent region encoding the variable V1, V2, and V3 domains of CXCR4-tropic HxB2 virus was replaced with the dual-tropic 89.6 viral strain. Using a recombinant vaccinia virus expressing 89.6 Env glycoprotein (vBD3) in a mouse challenge model, we observed that IL-21 plasmid produced sustained resistance to viral transmission when injected 5 days after DNA vaccination. Moreover, IL-21 in a synergistic manner with IL-15 expression vector augmented the vaccine-induced recall responses to the vBD3 challenge compared with those elicited by immunization in the presence of either cytokine alone. The synergistic combination of IL-21 and IL-15 plasmids promoted expansion of CD8+CD127+ memory T cell pools specific for a subdominant HLA-A2-restricted Env(121-129) epitope (KLTPLCVTL). Our results also show that coimmunization with IL-21 and IL-15 plasmid combination resulted in enhanced CD8+ T cell function that was partially independent of CD4+ T cell help in mediating protection against vBD3 challenge. Furthermore, the use of IL-21 and IL-15 genes was able to increase Ab-dependent cellular cytotoxicity and complement-dependent lysis of Env-expressing target cells through augmentation of Env-specific IgG Ab levels. These data indicate that the plasmid-delivered IL-21 and IL-15 can increase the magnitude of the response to DNA vaccines.</description><subject>Adjuvants, Immunologic - administration &amp; dosage</subject><subject>Adjuvants, Immunologic - genetics</subject><subject>AIDS Vaccines - administration &amp; dosage</subject><subject>AIDS Vaccines - genetics</subject><subject>AIDS Vaccines - immunology</subject><subject>Animals</subject><subject>Antibody-Dependent Cell Cytotoxicity - genetics</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Combined Modality Therapy</subject><subject>env Gene Products, Human Immunodeficiency Virus</subject><subject>Female</subject><subject>Gene Products, env - administration &amp; dosage</subject><subject>Gene Products, env - biosynthesis</subject><subject>Gene Products, env - genetics</subject><subject>Gene Transfer Techniques</subject><subject>HIV Antibodies - biosynthesis</subject><subject>HIV Antibodies - physiology</subject><subject>HIV-1 - genetics</subject><subject>HIV-1 - immunology</subject><subject>Human immunodeficiency virus 1</subject><subject>Immunization, Secondary</subject><subject>Interleukin-15 - administration &amp; dosage</subject><subject>Interleukin-15 - genetics</subject><subject>Interleukins - administration &amp; dosage</subject><subject>Interleukins - genetics</subject><subject>Interleukins - physiology</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Transgenic</subject><subject>Neutralization Tests</subject><subject>Rabbits</subject><subject>Vaccines, DNA - administration &amp; dosage</subject><subject>Vaccines, DNA - genetics</subject><subject>Vaccines, DNA - immunology</subject><subject>Vaccinia virus</subject><subject>Vaccinia virus - genetics</subject><subject>Vaccinia virus - immunology</subject><issn>0022-1767</issn><issn>1550-6606</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUc1u00AQXiEQDYUX4ID2xM1h_3dzrNI0tRQVhKBXy16Pk63sdfDaMX4lnpI1Dcqxl5mR5vsZzYfQR0qWgojVlyfXNINv6yXVeknn-gotqJQkUYqo12hBCGMJ1UpfoXchPBFCFGHiLbqiShspKV-gP6m3HeQBSryDE9Q493Fq_R5Orp9wW-FvXduD7d0JcDr7Af4O4dj6AAGnvhxspBYTvn24wY-5tS4CNr-PHYTg_B73B8D36WNC8caf8LaebHucBZ3H4wE8XrdNESklHl1_wOkuYfTfCXGiEm8hqt1CHc276T16U-V1gA_nfo1-3m1-rO-T3ddtur7ZJZYr3icrEEAIr9hKGmYErQpZWqN5SQ0DqEReiqrgBETclqbUTAjO8_k1XIEBya_R52fdeOivAUKfNS5YqOvcQzuETBmyMlqZF4FUM0m1nIHsGWi7NoQOquzYuSbvpoySbI4y-x9l5OiMzjWSPp3Vh6KB8kI5Z3exP7j9YXQdZKHJ6zrCaTaO40XpL9_gqUY</recordid><startdate>20060701</startdate><enddate>20060701</enddate><creator>Bolesta, Elizabeth</creator><creator>Kowalczyk, Aleksandra</creator><creator>Wierzbicki, Andrzej</creator><creator>Eppolito, Cheryl</creator><creator>Kaneko, Yutaro</creator><creator>Takiguchi, Masafumi</creator><creator>Stamatatos, Leonidas</creator><creator>Shrikant, Protul A</creator><creator>Kozbor, Danuta</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20060701</creationdate><title>Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery</title><author>Bolesta, Elizabeth ; Kowalczyk, Aleksandra ; Wierzbicki, Andrzej ; Eppolito, Cheryl ; Kaneko, Yutaro ; Takiguchi, Masafumi ; Stamatatos, Leonidas ; Shrikant, Protul A ; Kozbor, Danuta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-9e4e003f29582841fb5dc873d182eef4ad4fb30e4828d8d724433a006036e8e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adjuvants, Immunologic - administration &amp; dosage</topic><topic>Adjuvants, Immunologic - genetics</topic><topic>AIDS Vaccines - administration &amp; dosage</topic><topic>AIDS Vaccines - genetics</topic><topic>AIDS Vaccines - immunology</topic><topic>Animals</topic><topic>Antibody-Dependent Cell Cytotoxicity - genetics</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Combined Modality Therapy</topic><topic>env Gene Products, Human Immunodeficiency Virus</topic><topic>Female</topic><topic>Gene Products, env - administration &amp; dosage</topic><topic>Gene Products, env - biosynthesis</topic><topic>Gene Products, env - genetics</topic><topic>Gene Transfer Techniques</topic><topic>HIV Antibodies - biosynthesis</topic><topic>HIV Antibodies - physiology</topic><topic>HIV-1 - genetics</topic><topic>HIV-1 - immunology</topic><topic>Human immunodeficiency virus 1</topic><topic>Immunization, Secondary</topic><topic>Interleukin-15 - administration &amp; dosage</topic><topic>Interleukin-15 - genetics</topic><topic>Interleukins - administration &amp; dosage</topic><topic>Interleukins - genetics</topic><topic>Interleukins - physiology</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Transgenic</topic><topic>Neutralization Tests</topic><topic>Rabbits</topic><topic>Vaccines, DNA - administration &amp; dosage</topic><topic>Vaccines, DNA - genetics</topic><topic>Vaccines, DNA - immunology</topic><topic>Vaccinia virus</topic><topic>Vaccinia virus - genetics</topic><topic>Vaccinia virus - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bolesta, Elizabeth</creatorcontrib><creatorcontrib>Kowalczyk, Aleksandra</creatorcontrib><creatorcontrib>Wierzbicki, Andrzej</creatorcontrib><creatorcontrib>Eppolito, Cheryl</creatorcontrib><creatorcontrib>Kaneko, Yutaro</creatorcontrib><creatorcontrib>Takiguchi, Masafumi</creatorcontrib><creatorcontrib>Stamatatos, Leonidas</creatorcontrib><creatorcontrib>Shrikant, Protul A</creatorcontrib><creatorcontrib>Kozbor, Danuta</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bolesta, Elizabeth</au><au>Kowalczyk, Aleksandra</au><au>Wierzbicki, Andrzej</au><au>Eppolito, Cheryl</au><au>Kaneko, Yutaro</au><au>Takiguchi, Masafumi</au><au>Stamatatos, Leonidas</au><au>Shrikant, Protul A</au><au>Kozbor, Danuta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery</atitle><jtitle>Journal of Immunology</jtitle><addtitle>J Immunol</addtitle><date>2006-07-01</date><risdate>2006</risdate><volume>177</volume><issue>1</issue><spage>177</spage><epage>191</epage><pages>177-191</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><eissn>1365-2567</eissn><abstract>We investigated the ability of a plasmid-derived IL-21 delivered alone or in combination with the IL-15 gene to regulate immune responses to the HIV-1 envelope (Env) glycoprotein induced by DNA vaccination. Mice were injected with the gp140DeltaCFI(HXB2/89.6) vector expressing a modified Env glycoprotein with C-terminal mutations intended to mimic a fusion intermediate, in which the most divergent region encoding the variable V1, V2, and V3 domains of CXCR4-tropic HxB2 virus was replaced with the dual-tropic 89.6 viral strain. Using a recombinant vaccinia virus expressing 89.6 Env glycoprotein (vBD3) in a mouse challenge model, we observed that IL-21 plasmid produced sustained resistance to viral transmission when injected 5 days after DNA vaccination. Moreover, IL-21 in a synergistic manner with IL-15 expression vector augmented the vaccine-induced recall responses to the vBD3 challenge compared with those elicited by immunization in the presence of either cytokine alone. The synergistic combination of IL-21 and IL-15 plasmids promoted expansion of CD8+CD127+ memory T cell pools specific for a subdominant HLA-A2-restricted Env(121-129) epitope (KLTPLCVTL). Our results also show that coimmunization with IL-21 and IL-15 plasmid combination resulted in enhanced CD8+ T cell function that was partially independent of CD4+ T cell help in mediating protection against vBD3 challenge. Furthermore, the use of IL-21 and IL-15 genes was able to increase Ab-dependent cellular cytotoxicity and complement-dependent lysis of Env-expressing target cells through augmentation of Env-specific IgG Ab levels. These data indicate that the plasmid-delivered IL-21 and IL-15 can increase the magnitude of the response to DNA vaccines.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>16785513</pmid><doi>10.4049/jimmunol.177.1.177</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof Journal of Immunology, 2006-07, Vol.177 (1), p.177-191
issn 0022-1767
1550-6606
1365-2567
language eng
recordid cdi_proquest_miscellaneous_68098768
source MEDLINE; Wiley-Blackwell Free Backfiles(OpenAccess); Wiley Online Library Journals; IngentaConnect Open Access Journals; PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Adjuvants, Immunologic - administration & dosage
Adjuvants, Immunologic - genetics
AIDS Vaccines - administration & dosage
AIDS Vaccines - genetics
AIDS Vaccines - immunology
Animals
Antibody-Dependent Cell Cytotoxicity - genetics
CD8-Positive T-Lymphocytes - immunology
Combined Modality Therapy
env Gene Products, Human Immunodeficiency Virus
Female
Gene Products, env - administration & dosage
Gene Products, env - biosynthesis
Gene Products, env - genetics
Gene Transfer Techniques
HIV Antibodies - biosynthesis
HIV Antibodies - physiology
HIV-1 - genetics
HIV-1 - immunology
Human immunodeficiency virus 1
Immunization, Secondary
Interleukin-15 - administration & dosage
Interleukin-15 - genetics
Interleukins - administration & dosage
Interleukins - genetics
Interleukins - physiology
Mice
Mice, Inbred BALB C
Mice, Transgenic
Neutralization Tests
Rabbits
Vaccines, DNA - administration & dosage
Vaccines, DNA - genetics
Vaccines, DNA - immunology
Vaccinia virus
Vaccinia virus - genetics
Vaccinia virus - immunology
title Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T05%3A49%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Level%20and%20Longevity%20of%20Protective%20Immune%20Responses%20Induced%20by%20DNA%20Vaccine%20Expressing%20the%20HIV-1%20Env%20Glycoprotein%20when%20Combined%20with%20IL-21%20and%20IL-15%20Gene%20Delivery&rft.jtitle=Journal%20of%20Immunology&rft.au=Bolesta,%20Elizabeth&rft.date=2006-07-01&rft.volume=177&rft.issue=1&rft.spage=177&rft.epage=191&rft.pages=177-191&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.177.1.177&rft_dat=%3Cproquest_cross%3E68098768%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17251758&rft_id=info:pmid/16785513&rfr_iscdi=true